Yini i-Trastuzumab: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Trastuzumab iyindlela yokwelapha umdlavuza eqondiwe esiza ukulwa nezinhlobo ezithile zomdlavuza wamabele nesisu. Lo muthi usebenza njengemishini eqondisiwe, iqondise ngqo amangqamuzana omdlavuza anenani elikhulu lephrotheni ebizwa nge-HER2, kuyilapho ishiya amangqamuzana akho anempilo engathinteki kakhulu.

Uma udokotela wakho encoma i-trastuzumab, kusho ukuthi imiphumela yokuhlolwa komdlavuza wakho ibonisa ukuthi une-HER2 overexpression. Lokhu empeleni kukunika ukufinyelela ekwelashweni okuphumelela kakhulu okuye kwasiza abantu abaningi abanomdlavuza ofanayo ukuthi baphile isikhathi eside, impilo enempilo.

Yini i-Trastuzumab?

I-Trastuzumab wuhlobo lwe-immunotherapy olubizwa nge-monoclonal antibody. Cabanga ngayo njengephrotheni ekhethekile eyenzelwe ukuthi isebenze njengebhombu ehlakaniphile, ifune futhi inamathele kuma-HER2 proteins akhiqizwa ngokweqile kumangqamuzana athile omdlavuza.

Lo muthi ungowodwa ohlwini lwemithi ebizwa ngokuthi ukwelashwa okuqondiwe. Ngokungafani ne-chemotherapy yendabuko ethinta wonke amangqamuzana ahlukanisa ngokushesha, i-trastuzumab iqondise ngqo amangqamuzana omdlavuza anamazinga aphezulu e-HER2 protein. Le ndlela eqondiwe ivame ukusho imiphumela emincane eceleni uma iqhathaniswa ne-chemotherapy yendabuko.

Lo muthi unikezwa nge-IV infusion, ngokuvamile esibhedlela noma esikhungweni sokwelashwa komdlavuza. Ithimba lakho lezempilo lizokuqapha eduze ngesikhathi sokwelashwa ngakunye ukuze liqinisekise ukuphepha kwakho nokunethezeka kwakho.

Yini i-Trastuzumab Esetshenziselwa Yona?

I-Trastuzumab iphatha umdlavuza wamabele we-HER2-positive kanye neminye imidlava yesisu. Cishe ama-20-25% emidlavuza yamabele yi-HER2-positive, okusho ukuthi inenani elikhulu le-HER2 protein ebusweni bayo.

Ngomdlavuza wamabele, odokotela basebenzisa i-trastuzumab ezimweni eziningana. Ingalapha umdlavuza wamabele esigabeni sokuqala ngemva kokuhlinzwa ukuze isize ekuvikeleni umdlavuza ukuthi ungabuyi. Iphinde isetshenziswe ngomdlavuza wamabele othuthukile noma ometastatic oye wasabalala kwezinye izingxenye zomzimba.

Emdlalweni womgudu wokudla, i-trastuzumab isiza ukwelapha i-gastric adenocarcinoma ethuthukile lapho amaseli omdlavuzo ekhombisa i-HER2 ngokweqile. Udokotela wakho uzohlola izicubu zomdlavuza wakho ukuze aqinisekise ukuthi i-HER2-positive ngaphambi kokuqala lokhu kwelashwa.

Isebenza Kanjani I-Trastuzumab?

I-Trastuzumab isebenza ngokuvimba iphrotheni ye-HER2 emaseleni omdlavuzo, okuyeka ukukhula nokuhlukana kwawo. Lapho amaseli omdlavuzo ene-HER2 eningi kakhulu, akhula futhi asakazeke ngokushesha kunamaseli avamile.

Lo muthi unamathisela kuma-receptors e-HER2 njengokhiye ongqongqoza ngaphakathi kwesivalo. Uma inamathiselwe, ivimbela izimpawu zokukhula ekufinyeleleni iseli lomdlavuza. Lokhu empeleni kubeka amabhuleki ekukhuleni kwamaseli omdlavuzo futhi kungabangela ukuthi amaseli omdlavuzo afe.

I-Trastuzumab ithathwa njengokwelashwa komdlavuza okuqinile ngokulinganisela. Ngenkathi ivame ukuba mnene kune-chemotherapy yendabuko, iseyimithi enamandla edinga ukuqashwa ngokucophelela yithimba lakho lezempilo.

Kufanele Ngiyithathe Kanjani I-Trastuzumab?

I-Trastuzumab inikezwa njenge-IV infusion endaweni yezokwelapha, hhayi njengepilisi oyithatha ekhaya. Ithimba lakho lezempilo lizokulungisela futhi likunikeze umuthi.

Ngaphambi kokufakwa kwakho, akudingeki ukuthi uzile noma ugweme ukudla. Eqinisweni, ukuba nokudla okulula ngaphambi kwesikhathi kungakusiza ukuthi uzizwe ukhululekile ngesikhathi sokwelashwa. Phuza amanzi amaningi ukuze uhlale unamanzi, futhi gqoka izingubo ezikhululekile njengoba uzohlala isikhashana.

Ukufakwa kokuqala kuvame ukuthatha imizuzu engaba ngu-90, kuyilapho ukwelashwa okulandelayo kuvame ukuthatha imizuzu engu-30-60. Umhlengikazi wakho uzokuqapha eduze ngesikhathi sokufakwa kanye nesikhathi esithile ngemuva ukuze abheke noma yiziphi izindlela zokuphendula.

Kufanele Ngiyithathe Isikhathi Esingakanani I-Trastuzumab?

Ubude bokwelashwa kwe-trastuzumab busekelwe esimweni sakho esithile nohlobo lomdlavuza. Emdlalweni wamabele wesigaba sokuqala, ukwelashwa kuvame ukuthatha unyaka owodwa ngokufakwa njalo emavikini amathathu.

Ngesifo somdlavuza esithuthukile noma esisabalalayo, ungaqhubeka nokwelashwa uma nje kusiza ukulawula umdlavuza wakho futhi ukubekezelela kahle. Udokotela wakho uzohlola njalo ukuthi ukwelashwa kusebenza kahle kangakanani ngokusebenzisa izithombe kanye nokuhlolwa kwegazi.

Ungayeki ukuthatha i-trastuzumab ngaphandle kokuxoxa ngayo nodokotela wakho we-oncologist kuqala. Noma ngabe uzizwa kahle, imithi ingase isasebenza ukugcina umdlavuza wakho ulawulwa.

Yiziphi Imiphumela Eceleni ye-Trastuzumab?

Abantu abaningi bayayibekezelela kahle i-trastuzumab, kodwa njengayo yonke imithi, ingabangela imiphumela emibi. Izindaba ezinhle ukuthi imiphumela emibi engathi sína ayivamile, futhi ithimba lakho lezempilo liyazi ukuthi lingayiphatha kanjani.

Nansi imiphumela emibi evame kakhulu ongase uyithole ngesikhathi sokwelashwa:

• Ukukhathala nokuzizwa ukhathele kunokujwayelekile
• Ikhanda elivame ukuba lincane kuya kweliphakathi nendawo
• Ukucasuka, nakuba ngokuvamile kungabi kubi
• Ukuqunjelwa noma izinguquko emikhubeni yamathumbu
• Ukuqaqamba kwemisipha kanye nobuhlungu emalungeni
• Ukuphendula kokufakwa njengomkhuhlane, ama-chills, noma ukuqubuka kwesikhumba

Le miphumela emibi ejwayelekile ivame ukulawuleka futhi ivame ukuthuthuka njengoba umzimba wakho ujwayela ukwelashwa. Ithimba lakho lezempilo linganikeza imithi namasu okusiza ukunciphisa le miphumela.

Kukhona nemiphumela emibi engavamile kodwa engathi sína edinga ukunakekelwa kwezempilo ngokushesha:

• Izinkinga zenhliziyo, okuhlanganisa ukukhathala kwemisipha yenhliziyo
• Ukuphendula okukhulu komzimba ngesikhathi sokufakwa
• Izinkinga zamaphaphu njengobunzima bokuphefumula
• Izifo ezinzima ngenxa yokwehla komsebenzi wokuzivikela komzimba

Udokotela wakho uzoqapha umsebenzi wenhliziyo yakho njalo ngezivivinyo ezinjenge-echocardiograms noma ama-MUGA scans. Uma uzwa ubuhlungu besifuba, ukuphefumula kanzima, noma ukuvuvukala emilenzeni yakho, xhumana nethimba lakho lezempilo ngokushesha.

Ubani Ongafanele Athole i-Trastuzumab?

I-Trastuzumab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ilungele yini wena. Abantu abanezifo ezithile zenhliziyo kungenzeka bangakwazi ukuthatha lo muthi ngokuphepha.

Akufanele uthathe i-trastuzumab uma wazi ukuthi unokungezwani komzimba okukhulu nomuthi noma yiziphi izithako zawo. Udokotela wakho uzophinda aqaphele uma unomlando wezinkinga zenhliziyo, okuhlanganisa ukuhluleka kwenhliziyo noma ukungajwayelekile okukhulu kwesigqi senhliziyo.

Ukukhulelwa okunye okubalulekile okufanele kucatshangelwe. I-Trastuzumab ingalimaza umntwana ongakazalwa, ngakho-ke ukulawulwa kokuzalwa okusebenzayo kubalulekile ngesikhathi sokwelashwa kanye nasezinyangeni eziningana ngemuva. Uma ukhulelwe noma uhlela ukukhulelwa, xoxa ngalokhu nodokotela wakho ngokushesha.

Amagama Omkhiqizo we-Trastuzumab

I-Trastuzumab itholakala ngaphansi kwamagama amaningana omkhiqizo, i-Herceptin iyona engaziwa kakhulu. Lona kwakuyi-trastuzumab yokuqala eyavunywa yi-FDA futhi isisize iziguli iminyaka engaphezu kwamashumi amabili.

Izinhlobo eziningana ze-biosimilar manje sezitholakala, okuhlanganisa i-Ogivri, i-Ontruzant, i-Herzuma, ne-Trazimera. Ama-Biosimilars afana kakhulu nomuthi wokuqala futhi asebenza ngempumelelo efanayo, ngokuvamile ngezindleko eziphansi.

Udokotela wakho noma inkampani yomshuwalense ingase ikhethe uhlobo olulodwa ngaphezu kolunye, kodwa yonke imikhiqizo ye-trastuzumab evunywe yi-FDA ithathwa njengephumelela ngokulinganayo futhi iphephile ekwelashweni.

Ezinye izindlela ze-Trastuzumab

Uma i-trastuzumab ingakulungele, ezinye izindlela zokwelapha ezihloswe ku-HER2 ziyatholakala. I-Pertuzumab enye i-monoclonal antibody evame ukusetshenziswa ngokuhlangana ne-trastuzumab ukuze kuthuthukiswe ukusebenza kahle.

I-T-DM1 (ado-trastuzumab emtansine) iyindlela entsha ehlanganisa i-trastuzumab nomuthi we-chemotherapy. Lo muthi uletha i-chemotherapy ngqo emangqamuzaneni omdlavuza we-HER2-positive ngenkathi usindisa amaseli anempilo.

Kwabanye iziguli, izinketho ezintsha ezinjenge-tucatinib noma i-neratinib zingase zicatshangelwe, ikakhulukazi uma umdlavuza usabalale ebuchosheni noma uma ezinye izindlela zokwelapha zingasebenzi kahle.

Ingabe i-Trastuzumab Ingcono Kunezinye Izindlela Zokwelapha ze-HER2?

I-Trastuzumab isahlala iyindlela yokwelapha yegolide yomdlavuza oyi-HER2-positive, kodwa imithi emisha ivame ukusebenza kangcono uma isetshenziswa ndawonye kunokuba ithathe indawo yayo. Ukwelashwa ngakunye kunamandla akho futhi kukhethwa ngokuya ngesimo sakho esithile.

Uma kuqhathaniswa ne-pertuzumab yodwa, i-trastuzumab inerekhodi elide futhi nocwaningo oluningi olusekela ukusetshenziswa kwayo. Kodwa-ke, odokotela abaningi manje basebenzisa womabili amakhambi ndawonye ngoba agcwalisana ngesenzo sawo.

I-T-DM1 ingase ithandwe ezimweni ezithile, ikakhulukazi lapho umdlavuza usuthuthuke kwezinye izindlela zokwelapha. Udokotela wakho we-oncologist uzocabangela izinto ezinjengempilo yakho yonke, isigaba somdlavuza, kanye nokwelashwa kwangaphambilini lapho ekhetha indlela engcono kakhulu kuwe.

Imibuzo Evame Ukubuzwa Mayelana ne-Trastuzumab

Ingabe i-Trastuzumab Iphephile Kubantu Abanezifo Zenhliziyo?

I-Trastuzumab idinga ukuqapha inhliziyo ngokucophelela, kodwa abantu abaningi abanezimo zenhliziyo ezincane basengayithola ngokuphepha. Udokotela wakho uzohlola ukusebenza kwenhliziyo yakho ngaphambi kokuqala ukwelashwa futhi akuqaphe njalo.

Uma unezinkinga ezinkulu zenhliziyo, udokotela wakho angase alungise isimiso sokulinganisa noma akhethe ezinye izindlela zokwelapha. Okubalulekile ukuxhumana okuvulekile nethimba lakho lezempilo mayelana nanoma yiziphi izimpawu ezihlobene nenhliziyo noma ukukhathazeka.

Ngingenzani uma ngiphuthelwa ngengozi umthamo we-Trastuzumab?

Xhumana nethimba lakho lezempilo ngokushesha uma uphuthelwa ukufakwa kwe-trastuzumab okuhleliwe. Bazokusiza ukuthi uhlele kabusha ngokushesha ngangokunokwenzeka ukuze ugcine ukusebenza kokwelashwa kwakho.

Ukuphuthelwa imithamo ngezikhathi ezithile ngokuvamile ngeke kubangele izinkinga ezinkulu, kodwa kubalulekile ukuhlala eduze ngangokunokwenzeka kumugqa wakho wesikhathi ohleliwe. Udokotela wakho angase alungise umthamo wesikhathi esizayo ukuze akuvuselele.

Kufanele ngenzeni uma ngiba nokusabela okukhulu ngesikhathi sokufakwa?

Ukusabela okukhulu kokufakwa akuvamile, kodwa ithimba lakho lezempilo lilungele ukulisingatha ngokushesha. Bakugada eduze ngesikhathi sokufakwa ngakunye futhi banemithi elungele ukwelapha noma yikuphi ukusabela.

Uma uhlangabezana nezimpawu ezinjengobunzima bokuphefumula, ukuqubuka kwesikhumba okukhulu, noma isiyezi ngesikhathi sokufakwa, tshela umhlengikazi wakho ngokushesha. Ukusabela okuningi kungalawulwa ngokunciphisa izinga lokufakwa noma ukukunika imithi yokunciphisa ukusabela.

Ngingayeka nini ukuthatha i-Trastuzumab?

Isinqumo sokuyeka i-trastuzumab sincike ohlelweni lwakho lokwelashwa nokuthi usabela kahle kangakanani. Ngomdlavuza webele wesigaba sokuqala, ukwelashwa ngokuvamile kuqhubeka unyaka owodwa ogcwele ngaphandle uma kwenzeka imiphumela emibi emibi.

Ngomdlavuza othuthukile, ungaqhubeka nokwelashwa uma nje ulawula umdlavuza wakho futhi ukubekezelela kahle. Udokotela wakho uzohlola njalo inqubekela phambili yakho futhi axoxe nganoma yiziphi izinguquko ohlelweni lwakho lokwelashwa nawe.

Ngingathatha eminye imithi ngenkathi ngithatha i-Trastuzumab?

Imithi eminingi iphephile ukuyithatha nge-trastuzumab, kodwa njalo hlola nethimba lakho lezempilo ngaphambi kokuqala noma yini entsha. Lokhu kufaka phakathi imithi kadokotela, imithi etholakala ngaphandle kwe-oda, kanye nezithasiselo.

Eminye imithi ethinta ukusebenza kwenhliziyo ingase idinge ukuqashwa okukhethekile uma isetshenziswa nge-trastuzumab. Udokotela wakho uzobuyekeza yonke imithi yakho ukuze aqinisekise ukuthi isebenza ngokuphepha ndawonye.